Ryanodine sensitivity of the calcium release channel of sarcoplasmic reticulum.
Ryanodine modulates Ca2+ permeability in isolated terminal cisternae of sarcoplasmic reticulum, suggesting that it is a specific ligand for the calcium release channel. Our laboratory has purified the ryanodine receptor and demonstrated it to be equivalent to the feet structures, which are involved in the junctional association of the transverse tubule with the terminal cisternae. Recently, Smith, Coronado and Meissner have incorporated sarcoplasmic reticulum into bilayers and found a high conductivity channel (approximately .100 pS) which has a number of characteristics expected of the Ca2+ release channels in SR. We now find that the high conductivity channel in the bilayer is sensitive to ryanodine. Low concentrations of ryanodine (sub microM): (1) lock the channels in an open state; (2) prevent the action of ruthenium red (microM) to completely close the channel; and (3) much higher concentrations of ryanodine (300 microM) close the channel. In these three respects ryanodine acts similarly on the channel in the bilayer as in vesicles. Further, the bilayer studies provide new insight into the action of ryanodine on the channel in that: (1) ryanodine locks the channel in the open state, but the conductivity is reduced to about 40%; (2) ryanodine prevents ruthenium red from closing the channel, although there is a further decrease in the open current. These studies provide support that the high conductivity calcium channel in sarcoplasmic reticulum is involved in excitation-contraction coupling. By the same token the pharmacological action of ryanodine is pinpointed to the calcium release channel.
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002121:Calcium Channel Blockers; D007473:Ion Channels / Q000187:drug effects* / Q000378:metabolism; D008051:Lipid Bilayers / Q000378:metabolism; D011817:Rabbits; D012430:Ruthenium Red / Q000037:antagonists & inhibitors; D012433:Ryanodine / Q000494:pharmacology*; D012519:Sarcoplasmic Reticulum / Q000187:drug effects* / Q000378:metabolism
D000470:Alkaloids; D002121:Calcium Channel Blockers; D007473:Ion Channels; D008051:Lipid Bilayers; D012430:Ruthenium Red; D012433:Ryanodine; D002118:Calcium